Neurology

Vestibular migraine may be a relatively new diagnostic entity, but a new study shows it impacts around 6 million US adults. 

Primary care clinicians may be the first to note an abnormal headache pattern that calls for referral. What do you know about these not-so-simple headaches?

Noninvasive vagus nerve stimulation may be a viable method for the treatment of acute episodic migraine, according to a new study.

The first CGRP mAb has been FDA-approved, but why should you consider this novel category for migraine prevention? 

Take a closer look at how erenumab, the first CGRP inhibitor to win FDA-approval for migraine prevention, earned that spot.

Menstrual migraine can be a tricky diagnosis. Test your knowledge of the headaches and gather clinical tips with our 8-question quiz.

How much do you know about migraine/severe headache in the US? Take our 10-question quiz to find out. 

Results from a recent analysis of trends in US migraine prevalence show disease burden higher in populations that may be neglected. Are any of your patients at risk? 

Drugs that treat migraine come from a variety of classes and reflect on- and off-label use. How current are you?

In the largest study to date of blockade of the greater occipital nerve for migraine treatment, more than half of patients claimed a 50% reduction in pain. 

Neurostimulators are an emerging treatment option for migraine patients who want non-pharmacologic treatment. Find out what you know about the three devices approved for use in the US.

One of my migraine patients taught me that I need to ask the very hard questions if I want to offer the best possible care.

We top-line 5 migraine tracking & management apps that stand out from the many available and our app reviewer points out defining features.

When the cure becomes worse than the cause, it’s MOH. See what you know about these hard-to-treat headaches.

Whether they are chronic or episodic, a landmark study finds the net effect of parental migraine on teens is depression, anxiety, and disappointment. 

A headache specialist suggests 3 questions that can help maximize a short follow-up visit with these complex patients. 

The headache community is more than ready for a preventive migraine drug that works. Click through these slides for highlights of recently published trials.

There is a good deal of misinformation available about migraine headaches. Which of these 10 statements are myth and which are fact?

Migraine-especially with aura-is a CV risk factor, which makes treatment with ergots or triptans potentially problematic. The best approach?

It’s how much cannabis your patients with HIV infection smoke now-not over their lifetime-that appears to affect their cognition.

This month’s Special Report post-test allows you to gauge how much you have learned about current approaches to treating migraine headache.

Headaches that occur several days before menses as well as disabling headaches on days unrelated to menses... how would you help this young woman?

If the goal of headache therapy for adolescent migraineurs is a pain-free adult life, here's a road map.

What Rx for adolescent migraineurs? Ideal care for menstrual migraine? Perfect patient for new CGRP inhibitors? Answers in this PCP Special Report.

Slide Show: FDA drug approvals in the second quarter 2017 included these 10 for conditions seen in the primary care setting.